NCT01676428View on ClinicalTrials.gov

A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2015

Conditions
Cancer
Interventions
RADIATION

Radiotherapy

"The investigational treatment will be prescribed as a 2-tiered dose scheduled dependant on target size.~For lesions \<5cm, a single fraction of 26Gy will be prescribed. For lesions ≥5cm a fractionated course of 14Gy by 3 fractions will be prescribed, delivered at least 48 hours apart."

Trial Locations (1)

3002

Peter MacCallum Cancer Centre, East Melbourne

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT01676428 - A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases | Biotech Hunter | Biotech Hunter